Postoperative pain
Drug research and approvals for postoperative pain: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 775 studies of postoperative pain are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and the EU has 2 authorised medicines for it.
- Recruiting worldwide: 775
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 2
- STIL Block Versus Paravertebral Block for Pain Relief After Modified Radical MastectomyNCT07950982 · Not applicable · National Cancer Institute, Egypt · starts Nov 10, 2026
- Deep Rectus Sheath Block for Postoperative Pain in Laparoscopic Radical ProstatectomyNCT07948902 · Not applicable · Marmara University Pendik Training and Research Hospital · starts Nov 16, 2026
- IoC2-Guided Remifentanil Titration for Early Postoperative Pain After Laparoscopic CholecystectomyNCT07945613 · Not applicable · Yi Duan · starts Sep 18, 2026
- Sacral Erector Spinae Plane Block for Catheter-Related Bladder Discomfort After Holmium Laser Enucleation of the…NCT07944963 · Not applicable · Ankara Etlik City Hospital · starts Nov 19, 2026
- Study on Patients' Assessment of the Quality of Care During Their Treatment for Cholecystectomies at Limoges University…NCT07943338 · Not reported · University Hospital, Limoges · starts Jun 13, 2025
- AI Voice Calls Versus Text and Email Reminders for Questionnaire Response After Shoulder ArthroplastyNCT07940842 · Not applicable · Institut de Chirurgie Reparatrice Locomoteur et Sports · starts Nov 9, 2026
- Topical Corticosteroid and Wound Healing After Periodontal Flap SurgeryNCT07936812 · Not applicable · Kahramanmaras Sutcu Imam University · starts Jun 1, 2026
- Pectoral Nerve Block Versus Serratus Posterior Superior Intercostal Plane Block for Pain Control After MastectomyNCT07929090 · Not applicable · Bursa City Hospital · starts Nov 1, 2026
- Palatal Shield Technique for Pain Reduction and Wound Healing After Free Gingival Graft SurgeryNCT07926516 · Not applicable · Sameh Samy · starts Jun 5, 2026
Approved 9
- FentanylMu opioid receptor agonist
- MorphineMu opioid receptor agonist
- OxycodoneMu opioid receptor agonist
- OxymorphoneOpioid receptors; mu/kappa/delta agonist
- PromethazineHistamine H1 receptor antagonist
- SufentanilMu opioid receptor agonist
- BromfenacCyclooxygenase inhibitor
- NepafenacCyclooxygenase inhibitor
- ParecoxibCyclooxygenase-2 inhibitor
Phase 1 or earlier 1
How its trials ended
4,051 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 683 whose ending is known, 43% met their primary endpoint, 10% missed it and 46% stopped early.
- Completed, result not reported1,94448%
- Ongoing74318%
- Status unknown68117%
- Met its primary endpoint2967%
- Stopped: other or unclear1985%
- Missed its primary endpoint702%
- Stopped: enrollment or feasibility652%
- Stopped: lack of efficacy211%
- Stopped: sponsor or business decision20<1%
- Stopped: funding7<1%
- Stopped: safety6<1%
| Dec 11, 2007 | NevanacNepafenac | Novartis Europharm Limited | EMA ↗ |
| Mar 22, 2002 | DynastatParecoxib | Pfizer Europe MA EEIG | EMA ↗ |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA